Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Dec;82(6):706-714.
doi: 10.1053/j.ajkd.2023.04.013. Epub 2023 Jul 28.

Role of Anemia in Dementia Risk Among Veterans With Incident CKD

Affiliations
Observational Study

Role of Anemia in Dementia Risk Among Veterans With Incident CKD

Alain K Koyama et al. Am J Kidney Dis. 2023 Dec.

Abstract

Rationale & objective: Although some evidence exists of increased dementia risk from anemia, it is unclear whether this association persists among adults with CKD. Anemia may be a key marker for dementia among adults with CKD, so we evaluated whether anemia is associated with an increased risk of dementia among adults with CKD.

Study design: Retrospective cohort study.

Setting & participants: The study included 620,095 veterans aged≥45 years with incident stage 3 CKD (estimated glomerular filtration rate [eGFR]<60mL/min/1.73m2) between January 2005 and December 2016 in the US Veterans Health Administration system and followed through December 31, 2018, for incident dementia, kidney failure, or death.

Exposure: Anemia was assessed based on the average of hemoglobin levels (g/L) during the 2 years before the date of incident CKD and categorized as normal, mild, or moderate/severe anemia (≥12.0, 11.0-11.9,<11.0g/dL, respectively, for women, and≥13.0, 11.0-12.9,<11.0g/dL for men).

Outcome: Dementia and the composite outcome of kidney failure or death.

Analytical approach: Adjusted cause-specific hazard ratios were estimated for each outcome.

Results: At the time of incident CKD, the mean age of the participants was 72 years, 97% were male, and their mean eGFR was 51mL/min per 1.73m2. Over a median 4.1 years of follow-up, 92,306 veterans (15%) developed dementia before kidney failure or death. Compared with the veterans with CKD without anemia, the multivariable-adjusted models showed a 16% (95% CI, 14%-17%) significantly higher risk of dementia for those with mild anemia and a 27% (95% CI, 23%-31%) higher risk with moderate/severe anemia. Combined risk of kidney failure or death was higher at 39% (95% CI, 37%-40%) and 115% (95% CI, 112%-119%) for mild and moderate/severe anemia, respectively, compared with no anemia.

Limitations: Residual confounding from the observational study design. Findings may not be generalizable to the broader US population.

Conclusions: Anemia was significantly associated with an increased risk of dementia among veterans with incident CKD, underscoring the role of anemia as a predictor of dementia risk.

Plain-language summary: Adults with chronic kidney disease (CKD) often have anemia. Prior studies among adults in the general population suggest anemia is a risk factor for dementia, though it is unclear whether this association persists among adults with CKD. In this large study of veterans in the United States, we studied the association between anemia and the risk of 2 important outcomes in this population: (1) dementia and (2) kidney failure or death. We found that anemia was associated with a greater risk of dementia as well as risk of kidney failure or death. The study findings therefore emphasize the role of anemia as a key predictor of dementia risk among adults with CKD.

Keywords: Anemia; ESKD; chronic kidney disease; dementia; kidney failure.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Association between anemia at baseline and outcome in select baseline subgroups. Hazard ratios are stratified by levels of subgroups for age, sex, race/ethnicity, diabetes status, urinary albumin-to-creatinine ratio (UACR), transfusion status, availability of transferrin saturation (TSAT) measurement (yes/no), and TSAT (<20% / ≥20%) (among those with available TSAT), adjusting for all covariates included in the adjusted models shown in Table 2, provided it is not the stratifying variable. The rhombus symbol indicates the hazard ratios (HR) for mild anemia versus no anemia and the circle symbol indicates the HRs for moderate/severe versus no anemia. Abbreviations: P(int) = p value for the interaction test.

References

    1. Centers for Disease Control and Prevention. Chronic Kidney Disease in the United States, 2021. US Department of Health and Human Services. Accessed October 12, 2022. https://www.cdc.gov/kidneydisease/publications-resources/ckd-national-fa...
    1. Farina MP, Zhang YS, Kim JK, Hayward MD, Crimmins EM. Trends in Dementia Prevalence, Incidence, and Mortality in the United States (2000–2016). J Aging Health. Jan 2022;34(1):100–108. doi:10.1177/08982643211029716 - DOI - PMC - PubMed
    1. Wang V, Vilme H, Maciejewski ML, Boulware LE. The Economic Burden of Chronic Kidney Disease and End-Stage Renal Disease. Semin Nephrol. Jul 2016;36(4):319–30. doi:10.1016/j.semnephrol.2016.05.008 - DOI - PubMed
    1. Cantarero-Prieto D, Leon PL, Blazquez-Fernandez C, Juan PS, Cobo CS. The economic cost of dementia: A systematic review. Dementia (London). Nov 2020;19(8):2637–2657. doi:10.1177/1471301219837776 - DOI - PubMed
    1. Deckers K, Camerino I, van Boxtel MP, et al. Dementia risk in renal dysfunction: A systematic review and meta-analysis of prospective studies. Neurology. Jan 10 2017;88(2):198–208. doi:10.1212/WNL.0000000000003482 - DOI - PMC - PubMed

Publication types